Prilenia Therapeutics
Business Services · Netherlands · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Naarden, North Holland, NetherlandsWebsite
www.prilenia.comRevenue
<$5 MillionIndustry
About Prilenia Therapeutics
Prilenia Therapeutics is a clinical stage biotech company focused on developing treatments for Huntington's disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative and neurodevelopmental disorders. The company aims to address the urgent needs of patients and their families by advancing potential treatments, particularly through their research on pridopidine. Prilenia harnesses the brain's neuroprotective capabilities, specifically targeting the sigma-1 receptor to restore impaired pathways. Their mission is to change lives through innovation and collaboration, inviting individuals to join their efforts in making a difference.Explore more
Prilenia Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Prilenia Therapeutics Tech Stack
A closer look at the technologies used by Prilenia Therapeutics
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Prilenia Therapeutics
Sign Up For FreeTo access detailed company insights
Prilenia Therapeutics is a clinical stage biotech company focused on developing treatments for Huntington's disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative and neurodevelopmental disorders. The company aims to address the urgent needs of patients and their families by advancing potential treatments, particularly through th... Read More
